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Abstract
Background: The B cell antigen receptor (BCR) is a signaling complex that mediates the
differentiation of stage-specific cell fate decisions in B lymphocytes. While several studies have
shown differences in signal transduction components as being key to contrasting phenotypic
outcomes, little is known about the differential BCR-triggered gene transcription downstream of
the signaling cascades.
Results: Here we define the transcriptional changes that underlie BCR-induced apoptosis and
proliferation of immature and mature B cells, respectively. Comparative genome-wide expression
profiling identified 24 genes that discriminated between the early responses of the two cell types
to BCR stimulation. Using mice with a conditional Myc-deletion, we validated the microarray data
by demonstrating that Myc is critical to promoting BCR-triggered B-cell proliferation. We further
investigated the Myc-dependent molecular mechanisms and found that Myc promotes a BCR-
dependent clonal expansion of mature B cells by inducing proliferation and inhibiting differentiation.
Conclusion: This work provides the first comprehensive analysis of the early transcriptional
events that lead to either deletion or clonal expansion of B cells upon antigen recognition, and
demonstrates that Myc functions as the hub of a transcriptional network that control B-cell fate in
the periphery.
Background
The capacity of the mammalian immune system to dis-
criminate between foreign chemical entities and the
body's own components is critically dependent upon the
correct choice between life and death of immune cells.
While recognition of autoantigens by the B cell receptor
(BCR) on self-reactive immature B cells leads to their dele-
tion by apoptosis, foreign, antigen-specific, mature B lym-
phocytes respond to BCR engagement by clonal
expansion [1]. Increasing evidence suggests that immature
and mature B cells are differently adapted to signal trans-
duction via BCR [2,3]. Among the potential mechanisms
for regulating this functional dichotomy are differences in
the partitioning of BCR signaling components to lipid
rafts [4], the expression of B-cell co-receptors [5,6], basal
levels of distal effector molecules (e.g, transcription fac-
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activation of specific kinases and phosphatases. Immature
B cells do not proliferate in response to BCR triggering,
but they do mount an abortive attempt to enter the cell
cycle [9] and, similar to mature B cells, undergo a rapid
unfolded protein response [10], which indicates an adap-
tation to an increased demand for protein folding.
Recently, a model has emerged that suggests that B-cell
fate is determined by the balance between survival and
death signals initiated through the BCR [3].
Although both the BCR-induced death of immature B
cells and the BCR-induced expansion of conventional
mature B cells are critically dependent upon the de novo
transcription and translation of genes [11-14], no study to
date has investigated the mechanisms for the opposing
phenotypes at the transcriptome level. To address this
issue systematically, we undertook a genome-wide screen
to identify the BCR-regulated transcriptional module and
used functional studies to establish Myc as a hub of the
network that shapes the response to BCR-priming.
Methods
Mice and antibodies
For transcriptional analysis of the BCR-triggered
responses of T1 immature and mature B cells, male
C57BL/6 mice were studied at 4 weeks (The Jackson Lab-
oratory, Bar Harbor, Maine, USA). Mice with B lineage
cell-specific conditional Myc inactivation were generated
as described [15]. All experiments used background-, age-
and sex-matched controls. All mutant mice and their con-
trols were used at an age between 4 and 10 months. Affin-
ity-purified anti-mouse CD16/32, FITC-conjugated anti-
mouse B220, PE-conjugated anti-mouse CD23 and APC-
conjugated anti-mouse CD93/C1qRp antibodies were
purchased from eBioscience, (San Diego, California,
USA). Goat F(ab')2 anti-mouse IgM, μ-chain specific, was
purchased from Jackson ImmunoResearch (West Grove,
Pennsylvania, USA).
B cell purification, flow cytometry and cell culture
Single-cell suspensions were prepared from isolated
spleen. Untouched B cells were recovered by depletion of
non-B cells using the B Cell Isolation Kit (Miltenyi Biotec,
Bergisch Gladbach, Germany). The purity of B cells, which
was measured by the percentage of B220+ cells, was more
than 95%. Cells were either used as the total B cell fraction
or were pre-incubated with purified anti-CD16/32 to
block Fc receptors and further sorted as CD93+CD23- (T1
immature) and CD93-CD23+ (mature) by fluorescence
activated cell sorting (MoFlo, Cytomation, Glostrup, Den-
mark), as previously described [16,17]. B cells were cul-
tured at a density of 2 × 106 cells/ml in IMDM medium,
which was supplemented with 5% FCS, 100 U/ml of pen-
icillin, 100 μg/ml of streptomycin, 2 mM glutamine and
50 μM β-mercaptoethanol, in a humidified incubator at
37°C and 5% CO2. The cells were stimulated with or with-
out anti-μ IgM F(ab')2 at 30 μg/ml.
Phenotypic analyses
The proliferation of B cells was assessed by determining
their ATP content using a bioluminescent assay (ViaLight
Plus, Cambrex, East Rutherford, New Jersey, USA). Tests
were performed in 96-well plates at 1 × 105 cells/well
according to the manufacturer's instructions. Cell viability
was monitored by the exclusion of 0.4% trypan blue solu-
tion and visualized by light microscopy. The extent of
apoptosis was assessed by measuring the activities of cas-
pases 3 and 7 using the Apo-ONE Homogeneous Caspase-
3/7 Assay, according to the manufacturer's instructions
(Promega, Charbonnieres, France). The cell cycle was ana-
lyzed as previously described [18]. Phase-contrast micros-
copy was used to photograph isolated B cells in culture
after 48 h of treatment (Olympus 1X70, Olympus, Tokyo,
Japan). The levels of secreted IgM in sample supernatants
were determined using Mouse IgM ELISA Quantitation Kit
(Bethyl Laboratories, Montgomery, Texas, USA).
Microarrays, hybridization and data analysis
DNA arrays were prepared in house from the NIA Mouse
15K cDNA clone set [19]. Total RNA from sorted T1 imma-
ture and mature B cells of 10 mice was extracted using the
Trizol reagent (Invitrogen, Cergy Pontoise, France), fol-
lowed by one round of amplification with the Mes-
sageAmp™ Kit (Ambion ABI, Austin, Texas, USA). The
integrity of the RNA samples was verified using agarose gel
electrophoresis and the Bioanalyser 2100 (Agilent, Massy,
France). Amplified RNA was reverse-transcribed using
random primers, and aminoallyl-dUTP was incorporated
for indirect labeling with Cy3 and Cy5. Each labeled
cDNA sample was hybridized to the arrays at least six
times using a dye-swap strategy. All samples were hybrid-
ized against amplified Universal Mouse Reference RNA
(Stratagene, La Jolla, California, USA). Arrays were
scanned with the ScanArray5000 (Packard Instruments,
Rungis, France) or Genepix 4000B scanner, and feature
extraction was performed with the Genepix Pro 4.0 soft-
ware (Axon Instruments MDC, Sunnyvale, California,
USA). Data analysis, including intensity-dependent Low-
ess normalization of the raw data, was done with Gene-
Spring 7.0 software (Agilent, Massy, France). The data are
available in the Gene Expression Omnibus (GEO; acces-
sion number GSE9215). To analyze gene promoters, we
used the web-based Genomatix software (Genomatix,
Ann Harbor, Michigan, USA; http://www.genomatix.de/),
which is a bioinformatics tool that utilizes a large library
of matrix descriptions for known transcription factor
binding sites and algorithms to locate matches in DNA
sequences. To study how BCR-recruited molecules and
their interactions may determine the phenotypic outcome
of B cells, Ingenuity Pathway Analysis (IPA, Rewood City,
California, USA; http://www.ingenuity.com/) [20], whichPage 2 of 13
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tify the putative BCR-regulated functional module.
Quantitative real-time PCR and network analysis
qPCR was performed on total RNA from two independent
biological replicates. Samples were processed on an ABI
PRISM 7700 Sequence Detection System (Applied Biosys-
tems, Austin, Texas, USA) using the SYBR Green JumpStart
Taq ReadyMix (Sigma-Aldrich, Lyon, France). All qPCR
data were generated using Hprt1 as a reference (house-
keeping) gene. This gene was chosen based on the results
of the microarray analysis, which showed no significant
variation in the expression of Hprt1 among any of the
samples tested. We also verified our qPCR data by per-
forming calculations using a second house-keeping gene,
Cox1, and obtained similar results. Primer sequences are
available upon request.
Results
Opposite responses of immature and mature B cells to 
BCR triggering
To understand the transcriptional basis for the BCR-regu-
lated sensitivity to the apoptosis of immature B cells ver-
sus the proliferative response of mature B cells, we used
antibodies to surface IgM to mimic antigen binding by
cross-linking the BCR on both cell types in vitro. To assure
minimal developmental differences between both cell
populations, we chose to use freshly isolated splenic tran-
sitional immature B cells, as they represent the latest stage
of immature B cells and reside in a microenvironment
that is closest to the mature follicular compartment. After
negative selection of B cells, we used surface expression of
CD93 and CD23 as selection markers to sort cells, i.e. the
transitional 1 (T1) immature cells were CD93+CD23- and
the mature cells were CD93-CD23+ (Fig. 1A) [16,17].
Since these markers do not interact with the BCR, this
selection strategy allowed us to avoid uncontrolled trig-
gering of the receptor during sorting. In accordance with
previous observations, cross-linking of BCR on freshly iso-
lated cells induced apoptosis of the T1 immature cells and
a mitogenic response of the mature B cells (Fig. 1B–E)
[16]. The effects of BCR-stimulation on the sorted B cell
populations were assayed by ATP content measurements
to evaluate the proliferation status of cells, caspase 3/7
activity to measure the extent of apoptosis and trypan blue
exclusion to estimate the viability of cells in culture. In
addition, phase contrast microscopy showing large clus-
ters of proliferating mature B cells and much smaller
clumps of apoptotic immature cells upon BCR stimula-
tion confirmed the results of the above assays. These
observations prompted us to determine how as little as
the one day of differentiation that separates the two B cell
populations in the spleen results in the switch of the BCR-
mediated response from death to intense proliferation.
Changes in gene expression underlying BCR-induced 
apoptosis and proliferation
We analyzed transcriptional changes in response to BCR
ligation using cDNA microarrays containing 15,247
unique oligo(dT)-primed cDNA clones, which were pri-
marily derived from early embryonic cDNA libraries [19].
All samples were hybridized against commercially availa-
ble "universal" RNA, which allowed us to compare any
samples within our experimental design (Additional file
1A). By comparing the gene expression profiles of mature
versus T1 immature B lymphocytes, 44 genes (excluding
EST and RIKEN sequences) that differed significantly
between both differentiation stages were identified. The
observed changes in gene expression largely conformed to
observations from other cell types or agreed with their
known functions in B cell development, notably CD24a,
Fcgr2b, Id2, Myc and Prkcd (Table 1 and Additional file 2).
Interestingly, 82% of these genes were down-regulated in
mature B cells, and the majority has been described to act
against differentiation and proliferation or to favor apop-
tosis induction.
We next applied a hierarchical clustering analysis of gene
expression patterns over time to assess the relative similar-
ities between immature and mature B cells in response to
BCR engagement. We observed a clear segregation of anti-
IgM treated samples from untreated controls, with the lat-
ter being further separated by the stage of differentiation.
In contrast, treated samples were grouped according to the
time of incubation (Additional file 1B).
A similarity between the responses of immature and
mature cells to BCR cross-linking was also evident when
we examined the number of differentially expressed genes
relative to the zero hour time point. Approximately equiv-
alent numbers of genes were induced and repressed in
both cell populations at incubation time of 2 and 8 h. In
addition, treatment with anti-IgM influenced the expres-
sion of at least 3 times more genes than medium alone at
each time point (Additional file 1C). However, a general
analysis of gene functions following BCR triggering at 2 h
revealed a substantial difference in the early transcrip-
tional responses of immature and mature B cells. As
opposed to immature cells, BCR triggering on mature B
cells elicited a strong transcriptional perturbation of genes
that regulated biosynthesis, which indicated an adapta-
tion for the upcoming proliferative burst (Additional file
3). A much less pronounced induction of cell growth-pro-
moting genes in stimulated immature B cells likely reflects
their abortive attempt to proliferate, as previously
described [9,10]. Taken together, these data demonstrate
that, although the immature compartment exhibits a gene
expression pattern that is distinct from that of mature BPage 3 of 13
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Opposite responses of T1 immature and mature B cells to BCR triggeringFigure 1
Opposite responses of T1 immature and mature B cells to BCR triggering. (A) Fluorescence activated cell sorting 
(FACS) of magnetically separated, untouched B lymphocytes from the spleens of C57BL/6 mice using APC-conjugated CD93-
specific and PE-conjugated CD23-specific antibodies. T1 immature (CD93+, CD23-) and mature (CD93-, CD23+) B cells were 
sorted, as shown by the two rectangles. (B-E) Proliferation and apoptosis of sorted mature (M) and T1 immature (IM) B cells 
in response to BCR stimulation. Cells were incubated in vitro with (BCR) or without (ctrl) anti-μ F(ab')2 for the indicated peri-
ods of time and assayed for (B) ATP content, (C) caspase 3/7 activity and (D) trypan blue (TB) exclusion. Values are mean ± 
s.e.m. of three independent experiments. *, P < 0.01, compared to the respective control samples using Student's t-test (black 
and grey asterisks in (D) refer to the comparison of mature and immature samples, respectively). RFU, relative fluorescence 
units. (E) Phase contrast microscopy of mature and T1 immature B cells after 48 h of stimulation with anti-μF(ab')2 in culture. 
Lower panels show BCR-triggered large clusters of proliferating mature cells (left) and smaller groups of mainly apoptotic T1 
immature B cells (right). Scale bar, 50 μm. Non-B cells from spleen did not respond to the treatment with anti-μ IgM antibod-
ies, as determined by these assays (data not shown).
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BMC Genomics 2009, 10:323 http://www.biomedcentral.com/1471-2164/10/323cells, both cell populations respond to BCR triggering
with a relatively similar transcriptional program.
To identify the early genes that discriminate the responses
of the two cell types to BCR stimulation, we used two-way
ANOVA (P < 0.05) at the two-hour time point, while tak-
ing maturity stage and treatment as two independent var-
iables. This approach allowed us to identify BCR-induced
differences in gene expression with high sensitivity and to
discriminate them from any transcriptional variations due
to the developmental stage of the cells. The analysis iden-
tified 24 genes that likely determined the phenotypic out-
come of the mature and immature cells upon BCR
triggering. As expected, candidate genes from the top of
the list in Table 2 have been shown to stimulate cell
growth and proliferation, whereas genes from the bottom
have been associated with negative signaling. To validate
the array data, we confirmed the expression of 23 out of
Table 1: Differentially regulated genes between mature and T1 immature B cells.
Gene symbol Function M/IM
Syngr2 B-cell and neuronal differentiation 2.1
Idi1 cholesterol synthesis 1.7
Myc B-cell proliferation, differentiation 1.7
Litaf regulates inflammatory cytokine expression 1.5
Spag9 positively regulates MAPK signaling pathways 1.4
Rnf5 inhibits cell motility 1.4
Mfn2 mitochondrial fusion 1.3
Txnip immune cell differentiation 1.3
Mfap3 no data -1.3
Bnip3l apoptosis -1.3
Clta intracellular protein transport -1.5
Actb cytoskeleton structure -1.5
Pik3c2a survival and proliferation -1.6
Acad9 mitochondrial fatty acid oxidation -1.6
Prkcd inhibits B-cell proliferation and differentiation -1.6
Vezf1 angiogenesis -1.6
Pcyt1a apoptosis -1.7
Cecr2 chromatin remodeling -1.7
Zcchc17 no data -1.7
Coro1b neurite outgrowth -1.7
Atp5c1 no data -1.8
H2afz embryonic development -1.8
Cd24a B-cell apoptosis; development of immature B cells -2.1
Npc2 cholesterol transport -2.1
Emb cell adhesion during development -2.2
Fcgr2b inhibits B-cell proliferation -2.2
Emx2 neuronal growth and development -2.3
Cst3 reduces antigen presenting capacity of dendritic cells -2.3
Id2 inhibits B-cell differentiation -2.6
Cul7 regulates B-cell differentiation -2.6
Wwp1 T-cell differentiation; embryogenesis -2.7
Jun apoptosis, proliferation, differentiation -2.7
Ctsb apoptosis -2.8
Ifitm3 inhibits proliferation -3.1
Nr2f2 regulates organogenesis -3.1
Atp1b1 inhibits T-cell activation -3.2
Slc40a1 iron export -3.6
Phtf regulates spermatogenesis -3.7
Hoxb3 regeneration of stem cells -3.8
C1qa reduces T cell-dependent immune response -5.1
Laptm5 B-cell differentiation; inhibits maturation of dendritic cells -6.2
Hmox1 inhibits B-cell activation; inhibits T-cell proliferation -7.4
Hba-a1 oxygen transport -7.9
Lyzs defense response to bacteria -23.8
Genes discriminating transcriptional profiles of splenic mature and T1 immature B lymphocytes. The analysis was based on one-way ANOVA (P < 
0.01) of means of at least five replicate microarray experiments. Genes are ranked by the ratio of values for mature (M) versus immature (IM) B 
cells. For those genes with described functions, either their B-cell associated functions or, if unknown, primary functions in other cell types are 
listed. Differentially expressed EST and RIKEN sequences (46 in total) are not shown but can be recovered from the GEO database (GSE9215).Page 5 of 13
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total RNA isolated from two independent biological rep-
licates (Table 2 and Additional file 4).
Genes co-regulated by BCR signaling share several cis-
acting sequences in their promoter regions
Among the 24 genes, several of the most highly up-regu-
lated were co-clustered by k-means analysis (Fig. 2A &
Additional file 5A). Note that one of the clusters con-
tained five genes that had very similar expression profiles
across all the conditions. These five genes Crsp9, Ifrd1,
Myc, Marcksl1 and Ptger4, were also identified as the key
cell fate-regulators (Table 2). Assuming that co-expressed
genes are regulated by the same transcription factors and
share common binding sites in their upstream regions on
the one hand and that they should respond to BCR sign-
aling on the other hand, we screened the promoter
regions of differentially expressed genes at 2 h for com-
mon regulatory sequences. For this purpose, a web-based
MatInspector software from Genomatix was used to
search promoter regions of the five co-clustered genes for
known transcription factor binding sites. Interestingly, all
five genes shared two types of antibody producing cell-
specific binding sites (Fig. 2B) One included those that
were recognized by the ETS family of transcription factors,
such as Elk1, which is known to respond to BCR signaling
[21], and the other included binding sites for Pax5, which
is a key transcription factor that controls B-cell prolifera-
tion and differentiation and which has also been linked to
BCR stimulation [22,23]. We then tested for the statistical
significance of the occurrence of these binding sites com-
pared either to the entire genome or the promoters of all
genes. The results presented in Additional file 5B show
that Pax5, but not the ETS family members' binding sites,
are overrepresented in the five genes of interest. These data
indicate the putative binding sites and the identity of tran-
scription factors that may be responsible for the BCR-
mediated co-regulation of the most critical cell-fate deci-
sion-making genes, and it is intriguing that these are the
only predicted B cell-specific transcription factor binding
sites that are found in the promoters of all five genes.
Myc promotes BCR-dependent clonal expansion of 
mature B cells by inducing proliferation and inhibiting their 
differentiation
To examine whether the BCR-mediated up-regulation of
Myc was the cause for the BCR-dependent clonal expan-
sion of the B cells rather than a consequence of it, we used
Table 2: BCR-regulated genes discriminating immature and mature B cells at 2 h.
microarrays qPCR
BCR/ctrl BCR/ctrl
Gene symbol Function IM M M/IM IM M
Ptger4 B-cell activation and differentiation 1.7 4.6 2.8 1.8 4.8
Marcksl1 proliferation, cell adhesion, neurosecretion 2.6 6.1 2.4 2.2 4.3
Myc B-cell proliferation, differentiation, apoptosis 3.8 8.9 2.3 4.1 12.9
Crsp9 proliferation 1.4 3.0 2.1 1.7 3.1
Chchd4 no data 1.6 3.3 2.1 1.7 3.1
Wdr55 rRNA synthesis, cell cycle progression 1.3 2.4 1.9 1.7 1.9
Ifrd1 differentiation, proliferation 1.3 2.2 1.7 1.4 2.3
Eif3s1 T-cell activation 1.3 2.3 1.7 1.7 2.0
Idi1 cholesterol synthesis 1.6 2.7 1.7 1.6 2.3
M6pr lysosomal enzyme transport 1.4 2.5 1.7 1.1 2.0
Nola2 T-cell activation 1.4 2.3 1.7 1.7 2.2
Pdhx electron transport 1.8 3.0 1.7 -1.3 -1.4
Hrb spermiogenesis 1.5 2.3 1.5 1.1 2.5
Lyar cell growth 1.3 1.9 1.5 1.2 2.7
Irx3 heart and CNS development -1.0 1.4 1.4 -1.2 1.5
Rpo1-3 cell growth 1.1 1.5 1.4 1.1 1.5
Ptdss1 cell growth -1.0 1.4 1.4 -1.4 1.4
Stt3b oligosaccharyltransferase activity 1.9 1.3 -1.5 2.6 -1.3
Plekha2 B-cell receptor signaling -1.7 -2.6 -1.6 -2.5 -5.4
Fbxo22 no data 1.0 -1.6 -1.6 -1.4 -2.0
Jun apoptosis, proliferation, differentiation 1.1 -1.6 -1.8 -1.1 -3.4
3110001A13Rik no data -1.7 -3.6 -2.1 -1.6 -5.1
Spata13 no data -1.8 -4.8 -2.7 -2.5 -16.7
Tmem23 apoptosis -1.9 -5.3 -2.8 -2.8 -20.0
Differentially expressed genes in immature (IM) and mature (M) B cells at 2 h of BCR stimulation identified by two-way ANOVA (P < 0.05). 
Expression changes are shown as ratios of BCR triggered (BCR) versus control (ctrl) B cells at 2 h. Data are means of at least five replicate 
microarray experiments and at least two independent triplicate RT-PCR results.Page 6 of 13
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Gene expression profiles of T1 immature and mature B lymphocytes in response to BCR triggeringFigur  2
Gene expression profiles of T1 immature and mature B lymphocytes in response to BCR triggering. (A) k-
means clustering using standard correlations was applied at several k values to classify all 2,454 genes (represented by 3,505 
probes on the array) that showed differential expression between any sets of samples (see the key on the right). As shown in 
Additional file 5A, the result is independent of the selected k value. Shown are the clusters generated by running the analysis at 
k = 15. The cluster highlighted in red consists of Ptger4, Marcksl1, Myc, Crsp9, Ifrd1 and Pdhx. Data are means of normalized val-
ues of at least five microarray experiments. Note that the data from two different probes each (a, b) for Marcksl1 and Myc 
were used for clustering. (B) Transcription factor (TF) binding sites that are common to six promoter regions from the 
selected cluster of genes. A graphical representation of the matches shows the location for each binding site recognized by 
either the ETS family of TFs or Pax5 relative to the predicted transcription initiation sites (red arrows). As Pdhx was not vali-
dated by qPCR, it was excluded from the analysis. Note that we included two known promoter regions for Ptger4. Crsp9 is also 
known as Med7. The analysis was performed using the Genomatix software http://www.genomatix.de/. Only antibody produc-
ing cell-specific binding sites were analyzed. The statistics regarding the occurrence of these binding sites are provided in Addi-
tional file 5B.
A
B
1) IM 0h 6) M 0h
2) IM ctrl 2h 7) M ctrl 2h
3) IM ctrl 8h 8) M ctrl 8h
4) IM BCR 2h 9) M BCR 2h
5) IM BCR 8h 10) M BCR 8h
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cell-specific conditional Myc deletion in 60–70% of their
splenic B cells [15]. Stimulation of BCR on Myc-deficient
B cells resulted in a severely reduced proliferative response
(Fig. 3A), yet these cells resisted apoptosis (Fig. 3D) and
instead accumulated in the G0/G1 phase (Fig. 3B). Since
Myc has been shown to exert an essential role in B-cell
homeostasis [24], we further analyzed how Myc may con-
trol B-cell fate in response to BCR triggering. A survey of
cell cycle-regulating genes indicated that this defect in
BCR-triggered proliferation was mediated primarily by the
up-regulation of cyclin-dependent kinase inhibitors p16
and p27 (Fig. 3C). Interestingly, when we incubated MycΔ/
Δ cells in medium alone, we observed 3- to 5-fold increase
in antibody secretion relative to Mycfl/Δ or wild-type B
cells, which indicated that the Myc deletion facilitated ter-
minal differentiation to antibody-secreting plasma cells in
vivo (Fig. 3E). Indeed, MycΔ/Δ B cells exhibited a terminally
differentiated, plasma cell-like genotype that was charac-
terized by the mandatory up-regulation of Blimp-1 and a
near extinguishment of Aid, Bcl6, Mta3 and Pax5 expres-
sion, which are all known inhibitors of terminal B-cell dif-
ferentiation (Fig. 3F). These data indicate that Myc up-
regulation is critically important and causative for both
the mitogenic responsiveness and the differentiation
arrest upon BCR triggering.
Myc functions as a hub gene of the BCR-operated 
transcriptional network to control life and death of B cells
Since we found Myc to have the most profound effect on
BCR-recruited proliferation (Fig. 3A &3B) and know that
Myc is one of the key genes that regulates B-cell functions,
we investigated whether or not Myc affects the expression
of other genes in our list (Table 2) in order to orchestrate
the initial phase of the proliferative burst. For that pur-
pose, we performed qPCR analysis of the early genes that
were identified by two-way ANOVA upon BCR triggering
of follicular mature MycΔ/Δ B cells, which still retain
~30%–40% of the wild-type level of Myc transcripts [15].
Interestingly, in comparison to wild-type controls, most
genes were found to be significantly affected by the
reduced expression of Myc (Fig. 4A). Of note, genes with a
positive mature versus immature ratio, many of which
have previously been demonstrated to favor proliferation
(Table 2), showed either increased or unaltered expres-
sion upon BCR-priming. This is a likely result of an
attempt to compensate for the lack of Myc-driven
mitogenic signaling. In contrast, both known apoptosis-
promoting genes, Jun and Tmem23 [25,26], were down-
regulated, in accord with the observations that Myc-defi-
cient B cells are resistant to apoptosis triggering. The
induction of other genes with a negative mature versus
immature ratio seems less clear; however, their up-regula-
tion may be responsible for the cell cycle inhibition and
G0/G1 arrest that follows BCR-triggering in Myc-deficient
B cells. Thus, Myc acts as a hub of this network by directly
or indirectly coordinating transcriptional activity of both
stimulatory and inhibitory early response genes to control
BCR-signaled cell fate. Fig. 4B summarizes our findings by
depicting the identified Myc-regulated transcriptional net-
work in which the candidate decision-making genes
(Table 2) have been associated with Myc, based upon the
results presented in Fig. 4A. It is noteworthy that most
genes in this network, which mechanistically relates to the
switch of the BCR-mediated response from death to
intense proliferation of B cells in the periphery, have never
been described as potential Myc targets.
Discussion
The development of the correct repertoire of antigen spe-
cificity requires maturation of only those immune cells
that will be able to specifically recognize the invading
pathogens, but that stay inert towards all components of
the host organism. In discriminating self from non-self,
the mammalian immune system relies primarily on B
cells, which undergo a step-by-step maturation process to
attain immune competence [1,3]. Up until the last
moments prior to reaching the mature stage, transitional
immature B cells still undergo deletion by apoptosis upon
antigen recognition [17]. It is thus intriguing to observe
that the same signal can engage such contrasting cell fates
in two closely related cell types and that the same phe-
nomenon can be observed in vitro where culture condi-
tions are also kept the same. Here, we examined the
underlying mechanism that leads to these distinct biolog-
ical responses that are central to the proper functioning of
the adaptive immune system.
Regardless of the relatively solid evidence for the differen-
tial signal transduction pathways from the BCR, it has
been demonstrated that both immature and mature B
cell-responses are dependent upon de novo expression of
genes [11-14]. However, to the best of our knowledge,
only the study by Schories et al. investigated BCR-triggered
global transcriptional changes that lead to a defined phe-
notype [14]. This work focused solely on the anti-IgM-
induced apoptosis of an immature B-cell line, which
makes the interpretation of the results difficult for two
reasons. First, the "immortality" of a cell line significantly
changes the initial phenotype from a short-lived and
death-sensitive primary B cell to a robust and wildly pro-
liferating "lymphoma" cell that exhibits markedly delayed
kinetics of BCR-mediated death. Second, this study
neglected the fact that BCR signaling can also induce the
proliferation of B cells and that minute differences in gene
expression may divert the BCR response from apoptosis to
proliferation. Several other genome-wide transcriptional
analyses of B-cell responses to BCR stimulation have been
reported [27-30], but none of these studies considered
comparing the opposing phenotypes, which proved to be
critically important for the identification of the decision-
making genes. For example, these studies have alreadyPage 8 of 13
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Myc up-regulation is required for BCR-triggered proliferation and differentiation arrest of B cellsFigure 3
Myc up-regulation is required for BCR-triggered proliferation and differentiation arrest of B cells. (A-F) These 
experiments were performed on magnetically separated total untouched B cells from spleen of transgenic mice and their wild-
type controls. Cells were analyzed either freshly isolated or after in vitro incubation with (BCR) or without (ctrl) anti-μ F(ab')2 
for the indicated periods of time. (A) Measurements of ATP content in cells that were treated with anti-μ F(ab')2. Results are 
mean ± s.d. of two independent experiments performed in triplicate. (B) Cells were incubated with anti-μ F(ab')2 unperturbed 
for 48 h, photographed under phase-contrast microscope (top) and then stained with propidium iodide (PI) for cell cycle anal-
ysis (bottom). Live cell gating is shown. Data are representative of two or three experiments. (C) Transcriptional regulation of 
cell cycling genes in mature Myc+/+ and MycΔ/Δ B cells was examined by qPCR at 18 h of BCR-triggering. (D) Measurements of 
caspase 3/7 activity of cells treated with anti-μ F(ab')2. (E) ELISA of IgM in supernatants of unstimulated Mycfl/Δ and MycΔ/Δ B 
cells. Data are mean ± s.e.m. of three independent experiments. (F) Steady-state mRNA levels of terminal differentiation-asso-
ciated genes in resting mature Myc+/+ and MycΔ/Δ B cells.
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Myc functions as a hub gene of the BCR-operated transcriptional network to control life and death of B cellsFigure 4
Myc functions as a hub gene of the BCR-operated transcriptional network to control life and death of B cells. 
(A) Steady-state mRNA levels of genes selected by two-way ANOVA (Table 2) in mature Myc+/+ and MycΔ/Δ B cells treated 
with (BCR) or without (ctrl) anti-μ F(ab')2. Each presented value is a normalized ratio of the expression level of each gene in 
BCR versus control sample for each genotype, i.e., Myc+/+ and MycΔ/Δ. The data were normalized by dividing each ratio value by 
the wild-type BCR/ctrl ratio value for the corresponding gene. *, P < 0.05 (B) Myc-regulated transcriptional network control-
ling B-cell fate in response to BCR triggering. The candidate decision-making genes that were identified by the transcriptome 
analysis (Table 2) were associated with Myc according to the data (significance) presented in panel A. Genes were connected 
by dashed lines to indicate our indirect evidence for their interactions. Several genes (Wdr55, Spata13, Ptdss1, Rpo1-3, Hrb, 
Nola2, Idi1 and Ifrd1) were not connected to Myc because we did not observe any change in BCR/ctrl ratios when comparing 
both genotypes, i.e., Myc+/+ and MycΔ/Δ. Genes in orange have been reported as neighbors of the Myc-network in B cells [37], 
and genes with a red underscore or genes whose names are written in blue have been described as direct Myc targets in [38] 
and [39], respectively.
                       B
M6pr
BMC Genomics 2009, 10:323 http://www.biomedcentral.com/1471-2164/10/323identified Ptger4, Marcksl1, Myc, Ifrd1 and Jun among the
top most differentially expressed genes, but they failed to
discriminate them from other significantly regulated
genes when their contribution to the studied B-cell phe-
notype was assigned.
Therefore, the identification of the critical molecules
required a more structured approach to the complex tran-
scriptional programs that are triggered by the BCR. We
performed a comparative gene expression profiling of the
opposing responses of immature and mature primary B
cells to BCR cross-linking, which led us to identify 24
genes that could discriminate the early responses of the
two cell types. Two-way ANOVA allowed us to disregard
any transcriptional variations that were due to the devel-
opmental stage of the cells and to eliminate the genes
showing the equivalent regulation by the BCR in imma-
ture and mature cells.
Interestingly, although the identified genes have not been
mechanistically associated with BCR signaling before,
with the exception of Myc and Plekha2, their functions
described in other cell types largely agreed with the
observed changes in expression. Several of the up-regu-
lated genes in mature versus immature B cells have previ-
ously been shown to promote proliferation or
differentiation in various cells, while Myc and Ptger4 have
also been implicated in the development and homeostasis
of B lymphocytes [18,31]. In contrast, limited data exist
regarding the down-modulated genes. The pro-apoptotic
functions of Tmem23 and Jun have been demonstrated,
and Plekha2 is speculated to propagate negative signaling
in B cells upon BCR ligation [25,26,32]. These data,
together with the qPCR validation, suggest that the identi-
fied genes function to control the phenotypic outcome
that is signaled by the BCR.
Previous studies have shown that BCR triggering up-regu-
lates Myc expression in immature B cells at several differ-
entiation stages, as well as mature B cells [9,33,34]. They
have also suggested that Myc responsiveness to BCR liga-
tion is developmentally regulated [35]. However, these
studies focused mainly on the relationship between Myc
expression and the negative selection of B cells by apopto-
sis. Here, we describe Myc as a direct regulator of both pro-
liferation and apoptosis upon acute BCR signaling,
especially since B cells lacking Myc respond very poorly to
BCR ligation and are resistant to apoptosis. This is in
agreement with a previous study that found 2- to 3-fold
reduced numbers of total splenic Myc-deficient B cells and
an impaired mitogenic response of these cells to stimula-
tion with IL-4 and the anti-CD40 antibody [18]. Although
Myc has long been appreciated as an inhibitor of differen-
tiation in B cells [24,36], we showed here, for the first
time, that the absence of Myc alone facilitates their termi-
nal differentiation to antibody-secreting plasma cells.
Myc has recently been described as a "hub" gene that con-
trols several cellular processes in many cell types, includ-
ing B cells, by regulating up to 10 – 15% of all genes
[37,38]. This vastness of the Myc transcriptional network
makes it difficult to disentangle the contribution of Myc
to any given cellular phenotype. However, focusing our
study on the early transcriptional events of a specific bio-
logical process that occurs under defined in vitro condi-
tions allowed us to identify a few changes in gene
expression, including that of Myc, that discriminate
between the two opposing cell fates. An independent
experiment performed in a Myc-deficient background
revealed that most of the identified genes (62%; Fig. 4A)
are regulated by Myc. This extent of transcriptional control
thus far exceeds the estimated 10 – 15% of all genes that
are thought to be regulated by Myc and classifies Myc as
the hub gene of our network. Among the 21 genes of the
network, excluding the RIKEN sequence and Myc itself, 9
genes (43%; Hrb, Ifrd1, Jun, Nola2, Ptdss1, Ptger4, Spata13,
Stt3b and Eif3s1) were described as part of a Myc-network
in B cells [37,38], and an additional 2 genes (9.5%; M6pr
and Ptdss1) have been annotated in the Myc-database
[39]. The remaining 10 genes have never been reported as
either direct or indirect targets of Myc. One of the most
notable aspects of this network is the link between Myc
and Jun, which seems to play a key role in the regulation
of primary B cell-fate in response to BCR engagement.
Indeed, ChIP-on-chip data analysis supports Jun as a
direct target of Myc [40], and as we show here, Myc con-
trols the BCR-dependent regulation of Jun.
Conclusion
Our data identify the early changes in the transcriptional
mechanisms that discriminate between in vitro mimicked
negative selection by deletion and clonal expansion of B
lymphocytes in spleen. The approach we have taken in
this study provided a means to identify the decision-mak-
ing genes in an otherwise complex transcriptional pro-
gram that is triggered by the BCR. By integrating our data
with previous knowledge, we identify a BCR-operated
transcriptional network in which Myc functions as a mas-
ter regulator of the growth and differentiation of B cells.
Moreover, we showed that a reduced expression of Myc, as
the most highly connected hub gene, results in a gross
phenotypic change and the transcriptional perturbation
of several genes in its neighborhood, thus justifying the
role of Myc as a critical regulator of BCR-triggered life-or-
death decisions. Since the wrong choice between life and
death of B cells often leads to pathological conditions,
such as immunodeficiency, autoimmunity or cancer, a
thorough functional analysis of the molecules of the BCR-Page 11 of 13
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pies for such diseases.
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